TY - JOUR T1 - Accounting for imported cases in estimating the time-varying reproductive number of COVID-19 JF - medRxiv DO - 10.1101/2021.02.09.21251416 SP - 2021.02.09.21251416 AU - Tim K. Tsang AU - Peng Wu AU - Eric H. Y. Lau AU - Benjamin J. Cowling Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/12/2021.02.09.21251416.abstract N2 - Background Estimating the time-varying reproductive number, Rt, is critical for monitoring transmissibility of an emerging infectious disease during outbreaks. When local transmission is effectively suppressed, imported cases could substantially impact transmission dynamics.Methods We developed methodology to estimate separately the Rt for local cases and imported cases, since certain public health measures aim only to reduce onwards transmission from imported cases. We applied the framework to data on COVID-19 outbreaks in Hong Kong.Results We estimated that the Rt for local cases decreased from above one in the early phase of outbreak to below one after tightening of public health measures. Assuming the same infectiousness of local and imported cases underestimated Rt for local cases due to control measures targeting travelers.Conclusions When a considerable proportion of all cases are imported, the impact of imported cases in estimating Rt is critical. The methodology described here can allow for differential infectiousness of local imported cases.Competing Interest StatementBJC consults for Roche and Sanofi Pasteur. The authors report no other potential conflicts of interest. Funding StatementThis project was supported by the Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (grant no. COVID190118), and the Collaborative Research Fund from the University Grants Committee of Hong Kong (project no. C7123-20G).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approval is needed as the data were publicly available.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData on the incidence of coronavirus disease 2019 and influenza activity are freely available from the Centre for Health Protection website (https://www.chp.gov.hk/en/index.html). Computing code could be obtained by contacting the corresponding author. ER -